221 related articles for article (PubMed ID: 27765623)
1. Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.
Kim D; Ku SH; Kim H; Jeong JH; Lee M; Kwon IC; Choi D; Kim SH
J Control Release; 2016 Dec; 243():182-194. PubMed ID: 27765623
[TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.
Kim D; Hong J; Moon HH; Nam HY; Mok H; Jeong JH; Kim SW; Choi D; Kim SH
J Control Release; 2013 Jun; 168(2):125-34. PubMed ID: 23500061
[TBL] [Abstract][Full Text] [Related]
3. Cardiac RNAi therapy using RAGE siRNA/deoxycholic acid-modified polyethylenimine complexes for myocardial infarction.
Hong J; Ku SH; Lee MS; Jeong JH; Mok H; Choi D; Kim SH
Biomaterials; 2014 Aug; 35(26):7562-73. PubMed ID: 24917027
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
5. Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction.
Ku SH; Hong J; Moon HH; Jeong JH; Mok H; Park S; Choi D; Kim SH
Arch Pharm Res; 2015 Jul; 38(7):1317-24. PubMed ID: 25559468
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic Acid-Conjugated Polyethylenimine for Delivery of Heme Oxygenase-1 Gene in Rat Ischemic Stroke Model.
Oh J; Lee MS; Jeong JH; Lee M
J Pharm Sci; 2017 Dec; 106(12):3524-3532. PubMed ID: 28780392
[TBL] [Abstract][Full Text] [Related]
7. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
[TBL] [Abstract][Full Text] [Related]
8. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
9. MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine.
Moon HH; Joo MK; Mok H; Lee M; Hwang KC; Kim SW; Jeong JH; Choi D; Kim SH
Biomaterials; 2014 Feb; 35(5):1744-54. PubMed ID: 24280192
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
[TBL] [Abstract][Full Text] [Related]
11. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells.
Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH
Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297
[TBL] [Abstract][Full Text] [Related]
12. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
Lu ZX; Liu LT; Qi XR
Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
[TBL] [Abstract][Full Text] [Related]
14. Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain.
Oh J; Kim SM; Lee EH; Kim M; Lee Y; Ko SH; Jeong JH; Park CH; Lee M
Biomater Sci; 2020 Jun; 8(11):3063-3071. PubMed ID: 32348398
[TBL] [Abstract][Full Text] [Related]
15. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
[TBL] [Abstract][Full Text] [Related]
16. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
17. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs.
Kang SW; Lim HW; Seo SW; Jeon O; Lee M; Kim BS
Biomaterials; 2008 Mar; 29(8):1109-17. PubMed ID: 18022227
[TBL] [Abstract][Full Text] [Related]
18. A ternary-complex of a suicide gene, a RAGE-binding peptide, and polyethylenimine as a gene delivery system with anti-tumor and anti-angiogenic dual effects in glioblastoma.
Choi E; Oh J; Lee D; Lee J; Tan X; Kim M; Kim G; Piao C; Lee M
J Control Release; 2018 Jun; 279():40-52. PubMed ID: 29660374
[TBL] [Abstract][Full Text] [Related]
19. Heparin-conjugated polyethylenimine for gene delivery.
Jeon O; Yang HS; Lee TJ; Kim BS
J Control Release; 2008 Dec; 132(3):236-42. PubMed ID: 18597881
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury.
Li GH; Luo B; Lv YX; Zheng F; Wang L; Wei MX; Li XY; Zhang L; Wang JN; Chen SY; Tang JM; He X
J Transl Med; 2016 May; 14(1):116. PubMed ID: 27146579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
